Compare IRS & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
Current Price
Current Price
| Metric | IRS | AMLX |
|---|---|---|
| Founded | 1943 | 2014 |
| Country | Argentina | United States |
| Employees | 1392 | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | N/A | 2021 |
| Metric | IRS | AMLX |
|---|---|---|
| Price | $14.50 | $13.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $20.11 |
| AVG Volume (30 Days) | 171.3K | ★ 826.3K |
| Earning Date | 05-05-2026 | 03-03-2026 |
| Dividend Yield | ★ 10.24% | N/A |
| EPS Growth | N/A | ★ 65.46 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $380,786,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.66 | ★ N/A |
| Revenue Growth | N/A | ★ 1612.94 |
| 52 Week Low | $10.61 | $3.11 |
| 52 Week High | $19.14 | $17.49 |
| Indicator | IRS | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 43.22 | 43.72 |
| Support Level | $14.21 | $13.11 |
| Resistance Level | $14.60 | $15.37 |
| Average True Range (ATR) | 0.75 | 0.81 |
| MACD | -0.05 | -0.11 |
| Stochastic Oscillator | 36.67 | 1.72 |
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segments include Shopping Malls, which comprise lease and service revenues principally related to the rental of commercial and other spaces in the company's shopping malls; Offices, which include lease revenues and other service revenues related to office activities; Sales and Developments, which include the development, maintenance, and sales of undeveloped parcels of land and/or trading properties; Hotels, which mainly include revenues from rooms, catering, and restaurants; and others. The company generates the majority of its revenue from the Shopping Malls segment.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.